This is the second article in Pocono Review’s ongoing investigation into Rep. Dan Meuser. Read the first: Meuser Wins Primary Unopposed. His Campaign Spent $1.5 Million Anyway
LUZERNE COUNTY — When Dan Meuser filed his first financial disclosure as a member of Congress in 2018, he listed his estimated net worth at $31.7 million. Of that, $24 million was tied directly to Pride Mobility Products — the Duryea-based power wheelchair manufacturer his family founded in 1986.
By 2023, that stake had grown. His most recent annual disclosure values his personal ownership interest in Pride Mobility at between $25 million and $50 million. The same filing shows his Pride Mobility holdings generated S-Corp distributions of at least $1 million in 2023 — and as much as $5 million. When his wife’s stake and two dependent children’s trusts are included, the family collected between $1.3 million and $8 million from Pride that year alone.
That income flows from a company whose revenue depends on Medicare and Medicaid reimbursements — the same federal programs Meuser votes on.
He Never Left
Meuser built Pride Mobility with his brother Scott and their father Stan, joining the company in 1988 when it had $2 million in annual revenue. By the time he stepped down from his executive role in August 2008 to pursue public office, it was doing over $400 million. His brother Scott stayed on as chairman and CEO. Dan stayed on the board.
He is still there. His own House.gov biography describes him as a board member and consultant to Pride Mobility. The vast majority of the company’s revenue flows from Medicare and Medicaid reimbursements for durable medical equipment — power chairs, scooters, lifts — the same federal programs Meuser votes on every time healthcare legislation comes to the House floor.
Meuser’s congressional office does not disclose what he earns from Pride as a board member and consultant. He has never said publicly whether he recuses himself from votes affecting durable medical equipment or Medicare reimbursement.
The Money Loop
Before Meuser was in Congress, he was funding Pride’s PAC. FEC records show he donated $72,500 to Pride Mobility’s corporate PAC between 2003 and 2017 — in near-annual $5,000 installments while still a company executive. He was building the PAC that would eventually fund him.
Since his first congressional campaign in 2018, Pride Mobility’s PAC has contributed $37,999 to Meuser for Congress across 18 separate payments — every election cycle, without exception, through September 2024. In the 2023–2024 cycle, Pride’s PAC raised $31,000 total. Meuser’s campaign received $10,000 of it — roughly one in three dollars the PAC spent that cycle.
Pride’s 2018 cycle was the most aggressive in the PAC’s history: $81,900 raised, $92,950 spent. The timing wasn’t coincidental. It was Meuser’s first congressional race.
What Pride Is Asking Congress For
Pride Mobility lobbies to shape federal healthcare policy.
The company spent $160,000 lobbying Congress in 2021 — among its highest recorded annual totals. A Q3 2025 lobbying disclosure shows an additional $30,000 in a single quarter, on issues listed as: “DME industry relief, wheelchair upgrade legislation, Medicare coverage for power standing systems, wheelchair repair and service reform, and tariffs on medical devices.”
Those aren’t abstract policy categories. They describe specific legislative asks — coverage expansions, reimbursement protections, repair rights — that directly affect Pride’s revenue. The congressman who sits on the board of that company votes in the same Congress Pride’s lobbyists are working.
The overlap is not theoretical. Pride’s Q3 2025 lobbying disclosure lists “Medicare coverage for power standing systems” as an active lobbying priority. That same year, Meuser signed a congressional letter urging the Centers for Medicare and Medicaid Services to expand Medicare coverage to include standing systems in power wheelchairs — the precise policy Pride was paying lobbyists to advance. He also cosponsored H.R. 1703, the Choices for Increased Mobility Act of 2025, which requires Medicare to establish new billing codes for wheelchairs — directly affecting how Pride’s products are reimbursed. In the same cycle, Pride’s PAC paid his campaign $6,700.
Meuser’s votes on broader healthcare legislation also intersect with Pride’s business. In July 2025, he voted yes on H.R. 1, the One Big Beautiful Bill, which restructured Medicaid reimbursement and eligibility. Whatever one thinks of that legislation, Pride Mobility’s revenue depends substantially on Medicaid and Medicare reimbursements — meaning any vote touching those programs is a vote with a direct financial connection to a company paying Meuser at least $1 million a year. His constituents have no way to evaluate that connection because he has never disclosed it in the context of any of these votes.
There is no public record of Meuser recusing himself from any vote or committee action related to durable medical equipment, Medicare reimbursement, or wheelchair legislation since taking office in 2019.
The Oversight Chairman Who Can’t File on Time
Meuser currently chairs the House Financial Services Subcommittee on Oversight and Investigations. The job, by definition, is holding financial actors accountable for following the rules.
He has violated the STOCK Act twice.
The first time: in March 2020, at the bottom of the pandemic market crash, Meuser’s wife and children purchased between $107,000 and $600,000 in stock — Alphabet, Microsoft, Walt Disney, and Visa. Federal law required disclosure within 45 days. Meuser filed more than a year late. His explanation: human error by his broker. The penalty: $200.
The second time: in October 2024, his wife sold between $750,000 and $1.5 million in Nvidia stock. Meuser was nearly a year late reporting it — filing in August 2025. His explanation, delivered in an email to NOTUS that mentioned his broker six times: “The mistake was made solely by my brokerage and benefited me in no way.”
The penalty for a second violation: $200.
Beyond the late filings, Meuser’s family has sold Nvidia stock in every year from 2022 through 2026 — more than a dozen transactions in that stock alone, with total disclosed stock activity across his family accounts exceeding $2 million. Technology accounts for 58% of his disclosed trading activity. He chairs the subcommittee responsible for oversight of the financial sector.
The Workers
In June 2025, the U.S. District Court for the Middle District of Pennsylvania approved a $2.1 million class action settlement in Tufano v. Pride Mobility Products Corporation (3:24-cv-00765). About 1,500 Pride employees covered by the company’s Employee Stock Ownership Plan since May 2018 alleged that Pride mismanaged the retirement fund by parking assets primarily in Treasury bills and cash, generating returns well below what ERISA standards require. The settlement represents at least 40% of the class members’ estimated losses.
Pride denied all claims. No Pennsylvania outlet covered the settlement. Meuser said nothing about it publicly.
The Unanswered Questions
What federal ethics law requires is disclosure. What it doesn’t require — and what Meuser has never provided — is any accounting of how much Pride Mobility pays him, whether he has ever declined to vote on legislation that affects his company’s bottom line, or how a man collecting at least $1 million a year from a Medicare-dependent business thinks about his vote the next time Medicare reimbursement rates for power wheelchairs come up on the House floor.
The family company is still in Duryea, still run by his brother, still lobbying Congress. He’s still on the board.
Financial disclosure data from OpenSecrets (2018 filing) and House Clerk annual disclosure filing #10060930 (2023, filed August 13, 2024). PAC contribution history from ProPublica FEC Itemizer and FEC.gov (committee C00388132). Lobbying data from Senate Office of Public Records via OpenSecrets and Quiver Quantitative. STOCK Act violations reported by LegiStorm (August 2021) and NOTUS (August 2025). ESOP settlement from Bloomberg Law and CourtListener (3:24-cv-00765, M.D. Pa., approved June 2025).
Tips: tips@poconoreview.com | Corrections: corrections@poconoreview.com